Even though PAPSS2 is not significantly decreased by CNA, intra-tumor loss of PAPSS2 could favor androgen excess and hyperactivation of AR, which is critical for tumor growth and cancer progression. This evidence concerns the gene PAPSS2 and neoplasm.